Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.0058 | 0.9 |
mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | 0.0055 | 0.9 |
mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | -0.006 | 0.9 |
mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.0053 | 0.9 |
mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | -0.0051 | 0.9 |
mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | -0.0072 | 0.9 |
mRNA | QS11 | CTRPv2 | pan-cancer | AAC | -0.0091 | 0.9 |
mRNA | phloretin | CTRPv2 | pan-cancer | AAC | 0.0048 | 0.9 |
mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | 0.0046 | 0.9 |
mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.0046 | 0.9 |